Windtree Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 4.11 million compared to USD 8.13 million a year ago. Basic loss per share from continuing operations was USD 85.6799 compared to USD 258.4798 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.64 USD | -3.89% | -11.33% | -71.87% |
16/04 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-71.87% | 19.31L | |
+48.67% | 5.87TCr | |
-2.76% | 4.13TCr | |
+36.42% | 3.92TCr | |
-11.22% | 2.74TCr | |
+9.25% | 2.65TCr | |
-23.10% | 1.9TCr | |
+1.88% | 1.25TCr | |
+26.43% | 1.21TCr | |
+21.74% | 1.19TCr |
- Stock Market
- Equities
- WINT Stock
- News Windtree Therapeutics, Inc.
- Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023